Trial · NCT01467882
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Children With Luteinizing Hormone (LH) Suppression to Prepubertal Levels 30 Minutes After Leuprolide Stimulation at Month 6 | Month 6 | This is a lab test to see what percentage of participants were returned to normal before-puberty levels at Month 6. |
| Secondary | Percentage of Children With LH Suppression to Prepubertal Levels 30 Minutes After Leuprolide Stimulation at Months 1, 2, 3, 9 and 12 | at Months 1, 2, 3, 9 and 12 | This is a lab test to see what percentage of children were returned to normal before-puberty levels by the drug at each time point. |
| Secondary | Percentage of Children Maintaining LH Suppression at Prepubertal Levels 30 Minutes After Leuprolide Stimulation From Month 6 to 12 | from Month 6 to 12 | This is a lab test to see what percentage of children stayed at the normal before-puberty level from month 6 to month 12. |
| Secondary | Percentage of Children With LH Suppression (LH ≤ 4 IU/L)30 Minutes After Leuprolide Stimulation at Months 1, 2, 3, 6, 9 and 12 | at Months 1, 2, 3, 6, 9 and 12 | This is a lab test to see what percentage of children were returned to lower than normal before-puberty levels by the drug at each time point. |
| Secondary | Percentage of Children Maintaining LH Suppression at </= 4 IU/L 30 Minutes After Leuprolide Stimulation From Month 6 to 12 | from Month 6 to 12 | This is a lab test to see what percentage of children stayed at the lower than normal before-puberty level from month 6 to month 12. |
| Secondary | Change From Baseline in Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) at Months 1, 2, 3, 6, 9, and 12 | Baseline to Months 1, 2, 3, 6, 9, and 12 | |
| Secondary | Change From Baseline in Estradiol Levels at Months 1, 2, 3, 6, 9, and 12 | Baseline to Months 1, 2, 3, 6, 9, and 12 | |
| Secondary | Change From Baseline in Testosterone Levels at Months 1, 2, 3, 6, 9, and 12 | Baseline to Months 1, 2, 3, 6, 9, and 12 | |
| Secondary | Percentage of Children With Prepubertal Estradiol or Testosterone Levels at Months 1, 2, 3, 6, 9, and 12 | at Months 1, 2, 3, 6, 9, and 12 | |
| Secondary | Percentage of Children Without Higher Basal LH and Estradiol or Testosterone | at 2 days after second triptorelin injection (Day 171) | |
| Secondary | Change From Baseline in Height-for-age Z-score Per 2000 CDC Growth Charts at Months 6 and 12 | Baseline to Months 6 and 12 | |
| Secondary | Change From Baseline in Height-for-age Percentile Per 2000 CDC Growth Charts at Months 6 and 12 | Baseline to Months 6 and 12 | |
| Secondary | Change From Baseline in Growth Velocity at Months 6 and 12 | Baseline to Months 6 and 12 | |
| Secondary | Percentage of Participants Without Bone Age / Chronological Age Ratio Increase From Baseline at Months 6 and 12 | Baseline to Months 6 and 12 | |
| Secondary | Percentage of Children Achieving Stabilization of Sexual Maturation at Months 6 and 12 | at Months 6 and 12 | |
| Secondary | Percentage of Girls With Regression of Uterine Length Compared to Baseline at Months 6 and 12 | Baseline to Months 6 and 12 | |
| Secondary | Percentage of Boys With Absence of Progression of Testis Volumes Compared to Baseline at Months 6 and 12 | Baseline to Months 6 and 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01467882/registered